Telithromycin, which is the representative of ketolides, has come into market in 2001. It shows very good activity against some macrolide-resistant bacteria.
It showed that 19 strains had anti-MRSA activity. Then we selected a broad spectrum antimicrobial activity of endophytic fungi SIPI 3.0070 to identify strains.